An activatable nanocomposite as a hydrogen peroxide-catalytic oxygenerator for tumor imaging and enhanced photodynamic therapy
An activatable nanocomposite as a hydrogen peroxide-catalytic oxygenerator for tumor imaging and enhanced photodynamic therapy
复制标题
DOI:
10.1016/j.snb.2023.133663
复制
发表时间:
2023-06
期刊:
影响因子:
--
通讯作者:
Yan Huang;Lili Fu;Junjun Hou;Lingxiao Wang;Mingzhao Sun;Xiao Sun;Xiaoyan Wang;Lingxin Chen
中科院分区:
文献类型:
--
作者:
Yan Huang;Lili Fu;Junjun Hou;Lingxiao Wang;Mingzhao Sun;Xiao Sun;Xiaoyan Wang;Lingxin Chen
Photodynamic therapy has been used in the treatment of a variety of tumors, with a high degree of tumor inhibition and reduced side effects. However, the typically hypoxic micro-environment of tumor tissue has long been a key factor limiting the efficacy of tumor photodynamic therapy. Here, we designed and synthesized a nanocomposite RCDs@MnO2, which compounded red emissive carbon-dots (RCDs) with manganese dioxide nanosheets (MnO2), for catalyzes hydrogen peroxide (H2O2) to produce O2to improve tumor hypoxic environment. The precursor of RCDs showing a wide absorption band in the visible to near-infrared region (400–800 nm) with red emission (from 500 to 800 nm, peaking at 640 nm). These prepared RCDs could produce1O2under 550 nm laser irradiation to achieve the purpose of photodynamic therapy. In addition, MnO2could quench the fluorescence emission of RCDs and exhibit an RCDs@MnO2fluorescence “off-on” function in tumor cells and tissues. RCDs@MnO2could achieve the fluorescence imaging of tumor cells and tumor tissues, and improve the tumor hypoxic environment and enhance photodynamic treatment effect. RCDs@MnO2has the powerful potential to be applied to fluorescence imaging of tumor tissue and significantly improve the photodynamic therapy of tumor, when investigated in vitro and in vivo.